Technical Analysis for ORGS - Orgenesis Inc.

Grade Last Price % Change Price Change
grade C 4.5 3.93% 0.17
ORGS closed up 3.93 percent on Wednesday, August 21, 2019, on 22 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical ORGS trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 50 DMA Bearish 3.93%
180 Bearish Setup Bearish Swing Setup 3.93%
Stochastic Reached Oversold Weakness 3.93%
BB Squeeze Ended Range Expansion 3.93%
Below Lower BB Weakness 3.93%
Lower Bollinger Band Touch Weakness 3.93%
Oversold Stochastic Weakness 3.93%
50 DMA Support Bullish -0.88%

Older signals for ORGS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Orgenesis Inc. is a regenerative therapy company. The Company operates through two segments: Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CTB). The CDMO activity is operated by the Company's subsidiary, MaSTherCell SA, which specializes in cell therapy development for advanced medicinal products. MaSTherCell is providing two types of services to its customers: process and assay development services and good manufacturing practice (GMP) contract manufacturing services. The CTB activity is based on its technology that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating (converting) them into pancreatic beta cell-like insulin producing cells for patients with Type I Diabetes. It intends to advance a product that combines cell-based therapy and regenerative medicine, Autologous Insulin Producing (AIP) cells, into clinical development.
Biotechnology Diabetes Stem Cells Endocrine System Hormones Regenerative Medicine Cell Therapy Insulin Peptide Hormones Contract Manufacturing Services Diabetes Mellitus Type 1 Embryonic Stem Cell Medicinal Products
Is ORGS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.25
52 Week Low 3.78
Average Volume 24,433
200-Day Moving Average 4.8339
50-Day Moving Average 4.4542
20-Day Moving Average 4.607
10-Day Moving Average 4.589
Average True Range 0.2578
ADX 17.62
+DI 15.5429
-DI 13.5187
Chandelier Exit (Long, 3 ATRs ) 4.2266
Chandelier Exit (Short, 3 ATRs ) 5.0534
Upper Bollinger Band 4.838
Lower Bollinger Band 4.376
Percent B (%b) 0.27
BandWidth 10.028218
MACD Line 0.0043
MACD Signal Line 0.0436
MACD Histogram -0.0393
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.76
Resistance 3 (R3) 4.73 4.61 4.71
Resistance 2 (R2) 4.61 4.55 4.63 4.70
Resistance 1 (R1) 4.56 4.51 4.59 4.59 4.68
Pivot Point 4.44 4.44 4.46 4.46 4.44
Support 1 (S1) 4.39 4.38 4.42 4.42 4.32
Support 2 (S2) 4.27 4.34 4.29 4.30
Support 3 (S3) 4.22 4.27 4.29
Support 4 (S4) 4.25